19-17337646-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032620.4(GTPBP3):c.35C>A(p.Ala12Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000846 in 1,181,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032620.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTPBP3 | NM_032620.4 | c.35C>A | p.Ala12Glu | missense_variant | 1/9 | ENST00000324894.13 | NP_116009.2 | |
GTPBP3 | NM_133644.4 | c.35C>A | p.Ala12Glu | missense_variant | 1/8 | NP_598399.2 | ||
GTPBP3 | NM_001128855.3 | c.35C>A | p.Ala12Glu | missense_variant | 1/9 | NP_001122327.1 | ||
GTPBP3 | NM_001195422.1 | c.120-362C>A | intron_variant | NP_001182351.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTPBP3 | ENST00000324894.13 | c.35C>A | p.Ala12Glu | missense_variant | 1/9 | 1 | NM_032620.4 | ENSP00000313818.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 8.46e-7 AC: 1AN: 1181446Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 564622
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 20, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with GTPBP3-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces alanine with glutamic acid at codon 12 of the GTPBP3 protein (p.Ala12Glu). The alanine residue is weakly conserved and there is a moderate physicochemical difference between alanine and glutamic acid. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.